central role e3 ubiquitin ligase mg53 insulin resistance metabolic disorders
insulin resistance fundamental pathogenic factor present various metabolic disorders including obesity type diabetes although skeletal muscle accounts % insulin-stimulated glucose disposal mechanism underlying muscle insulin resistance poorly understood show mice muscle-specific mitsugumin mg53 also called trim72 mediates degradation insulin receptor insulin receptor substrate irs1 upregulated causes metabolic syndrome featuring insulin resistance obesity hypertension dyslipidaemia mg53 expression markedly elevated models insulin resistance mg53 overexpression suffices trigger muscle insulin resistance metabolic syndrome sequentially conversely ablation mg53 prevents diet-induced metabolic syndrome preserving insulin receptor irs1 insulin signalling integrity mechanistically mg53 acts e3 ligase targeting insulin receptor irs1 ubiquitin-dependent degradation comprising central mechanism controlling insulin signal strength skeletal muscle findings define mg53 novel therapeutic target treating metabolic disorders associated cardiovascular complications
